{"id":156365,"date":"2021-12-21T01:45:44","date_gmt":"2021-12-21T06:45:44","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/basilea-receives-usd-10-million-milestone-payment-related-to-approval-of-antifungal-cresemba-isavuconazole-in-china\/"},"modified":"2024-08-18T11:43:30","modified_gmt":"2024-08-18T15:43:30","slug":"basilea-receives-usd-10-million-milestone-payment-related-to-approval-of-antifungal-cresemba-isavuconazole-in-china","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/basilea-receives-usd-10-million-milestone-payment-related-to-approval-of-antifungal-cresemba-isavuconazole-in-china.php","title":{"rendered":"Basilea receives USD 10 million milestone payment related to approval of antifungal Cresemba\u00ae (isavuconazole) in China"},"content":{"rendered":"<p><![CDATA[Ad hoc announcement pursuant to Art. 53 LR]]><\/p>\n<p>Read the original post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2021\/12\/21\/2355753\/0\/en\/Basilea-receives-USD-10-million-milestone-payment-related-to-approval-of-antifungal-Cresemba-isavuconazole-in-China.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Basilea receives USD 10 million milestone payment related to approval of antifungal Cresemba\u00ae (isavuconazole) in China\">Basilea receives USD 10 million milestone payment related to approval of antifungal Cresemba\u00ae (isavuconazole) in China<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the original post: Basilea receives USD 10 million milestone payment related to approval of antifungal Cresemba\u00ae (isavuconazole) in China <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/basilea-receives-usd-10-million-milestone-payment-related-to-approval-of-antifungal-cresemba-isavuconazole-in-china.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-156365","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/156365"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=156365"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/156365\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=156365"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=156365"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=156365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}